Pharmacogenomics in allogeneic hematopoietic stem cell transplantation: Implications on supportive therapies and conditioning regimens

被引：0
|
作者：
Morris, Sarah A. [1 ,2 ]
Nguyen, D. Grace [1 ,2 ]
Patel, Jai N. [1 ,2 ]
机构：
[1] Atrium Hlth, Dept Canc Pharmacol & Pharmacogen, 1021 Morehead Med Dr, Charlotte, NC 28204 USA
[2] Atrium Hlth, Levine Canc Inst, 1021 Morehead Med Dr, Charlotte, NC 28204 USA
来源：
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY | 2023年 / 36卷 / 02期
关键词：
Pharmacogenomics; Pharmacogenetics; Supportive care; Bone marrow transplant; Hematopoietic stem cell transplantation; Allogeneic transplantation; VERSUS-HOST-DISEASE; CONSORTIUM CPIC GUIDELINES; DRUG-METABOLIZING-ENZYMES; CYCLOPHOSPHAMIDE PHARMACOKINETICS; CYP2C19; POLYMORPHISMS; GENE POLYMORPHISMS; PEDIATRIC-PATIENTS; VORICONAZOLE; ASSOCIATION; TACROLIMUS;
D O I：
10.1016/j.beha.2023.101470
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Allogeneic hematopoietic stem cell transplantation mortality has declined over the years, though prevention and management of treatment-related toxicities and post-transplant complications remains challenging. Applications of pharmacogenomic testing can potentially mitigate adverse drug outcomes due to interindividual variability in drug metabolism and response. This review summarizes clinical pharmacogenomic applications relevant to hematopoietic stem cell transplantation, including antifungals, immunosuppressants, and supportive care management, as well as emerging pharmacogenomic evidence with conditioning regimens.
引用
收藏
页数：11
相关论文
共 50 条
  • [1] Thiotepa-based conditioning regimens in allogeneic hematopoietic stem cell transplantation for patients with myelofibrosis
    Dulery, R.
    Giannotti, F.
    Battipaglia, G.
    Ruggeri, A.
    Brissot, E.
    Malard, F.
    Sestili, S.
    Belhocine, R.
    Vekhoff, A.
    Gueye, M. S.
    Lapusan, S.
    Adaeva, R.
    Isnard, F.
    Legrand, O.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S337 - S337
  • [2] Costs of Hematopoietic Stem Cell Transplantation and Associated Conditioning Regimens
    Quock, Tiffany P.
    Broder, Michael S.
    Chang, Eunice
    Reddy, Sheila R.
    Arai, Sally
    Agarwal-Hashmi, Rajni
    Villa, Kathleen F.
    BLOOD, 2015, 126 (23)
  • [3] Costs of Hematopoietic Stem Cell Transplantation and Associated Conditioning Regimens
    Quock, Tiffany P.
    Broder, Michael S.
    Chang, Eunice
    Reddy, Sheila R.
    Arai, Sally
    Agarwal-Hashmi, Rajni
    Villa, Kathleen F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S282 - S282
  • [4] Intravenous Busulfan Pharmacokinetics in Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Dosing Weight
    Bradley, Amber M.
    Evans, Sarah
    DeRemer, David
    Awan, Farrukh Tauseef
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S373 - S374
  • [5] Antibody based conditioning for allogeneic hematopoietic stem cell transplantation
    Saha, Asim
    Blazar, Bruce R.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [6] Allogeneic stem cell transplantation for autoimmune diseases: nonmyeloablative conditioning regimens
    Oyama, Y
    Traynor, AE
    Barr, W
    Burt, RK
    BONE MARROW TRANSPLANTATION, 2003, 32 (Suppl 1) : S81 - S83
  • [7] Differences between the different conditioning regimens for allogeneic stem cell transplantation
    Schattenberg, Anton V. M. B.
    Levenga, Tjakiena H.
    CURRENT OPINION IN ONCOLOGY, 2006, 18 (06) : 667 - 670
  • [8] Allogeneic stem cell transplantation for autoimmune diseases: nonmyeloablative conditioning regimens
    Y Oyama
    A E Traynor
    W Barr
    R K Burt
    Bone Marrow Transplantation, 2003, 32 : S81 - S83
  • [9] Costs of Allogeneic Hematopoietic Cell Transplantation Using Reduced Intensity Conditioning Regimens
    Khera, Nandita
    Emmert, Amy
    Storer, Barry E.
    Sandmaier, Brenda M.
    Alyea, Edwin P.
    Lee, Stephanie J.
    ONCOLOGIST, 2014, 19 (06): : 639 - 644
  • [10] Conditioning regimens for allogeneic hematopoietic stem cell transplants in acute myeloid leukemia
    Jethava, Y. S.
    Sica, S.
    Savani, B.
    Socola, F.
    Jagasia, M.
    Mohty, M.
    Nagler, A.
    Bacigalupo, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 (11) : 1504 - 1511
12345